Copyright Reports & Markets. All rights reserved.

Global Biolayer Interferometry (BLI) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biolayer Interferometry (BLI) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Affinity and Kinetic Analysis
    • 1.3.3 Drug and Antibody Screening
    • 1.3.4 Drug and Antibody Discovery
    • 1.3.5 Protein Quantification
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biolayer Interferometry (BLI) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Diagnostics
    • 1.4.4 Biotechnology
    • 1.4.5 Scientific Research
    • 1.4.6 Others
  • 1.5 Global Biolayer Interferometry (BLI) Market Size & Forecast
    • 1.5.1 Global Biolayer Interferometry (BLI) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Biolayer Interferometry (BLI) Sales Quantity (2019-2030)
    • 1.5.3 Global Biolayer Interferometry (BLI) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Ichor Life Sciences, Inc
    • 2.1.1 Ichor Life Sciences, Inc Details
    • 2.1.2 Ichor Life Sciences, Inc Major Business
    • 2.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product and Services
    • 2.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Ichor Life Sciences, Inc Recent Developments/Updates
  • 2.2 Creative BioMart
    • 2.2.1 Creative BioMart Details
    • 2.2.2 Creative BioMart Major Business
    • 2.2.3 Creative BioMart Biolayer Interferometry (BLI) Product and Services
    • 2.2.4 Creative BioMart Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Creative BioMart Recent Developments/Updates
  • 2.3 GenScript
    • 2.3.1 GenScript Details
    • 2.3.2 GenScript Major Business
    • 2.3.3 GenScript Biolayer Interferometry (BLI) Product and Services
    • 2.3.4 GenScript Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 GenScript Recent Developments/Updates
  • 2.4 ROCKLAND IMMUNOCHEMICALS, INC
    • 2.4.1 ROCKLAND IMMUNOCHEMICALS, INC Details
    • 2.4.2 ROCKLAND IMMUNOCHEMICALS, INC Major Business
    • 2.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product and Services
    • 2.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments/Updates
  • 2.5 BPS Bioscience, Inc
    • 2.5.1 BPS Bioscience, Inc Details
    • 2.5.2 BPS Bioscience, Inc Major Business
    • 2.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product and Services
    • 2.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BPS Bioscience, Inc Recent Developments/Updates
  • 2.6 Creative Proteomics
    • 2.6.1 Creative Proteomics Details
    • 2.6.2 Creative Proteomics Major Business
    • 2.6.3 Creative Proteomics Biolayer Interferometry (BLI) Product and Services
    • 2.6.4 Creative Proteomics Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Creative Proteomics Recent Developments/Updates
  • 2.7 Creative Biostructure
    • 2.7.1 Creative Biostructure Details
    • 2.7.2 Creative Biostructure Major Business
    • 2.7.3 Creative Biostructure Biolayer Interferometry (BLI) Product and Services
    • 2.7.4 Creative Biostructure Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Creative Biostructure Recent Developments/Updates
  • 2.8 Profacgen
    • 2.8.1 Profacgen Details
    • 2.8.2 Profacgen Major Business
    • 2.8.3 Profacgen Biolayer Interferometry (BLI) Product and Services
    • 2.8.4 Profacgen Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Profacgen Recent Developments/Updates
  • 2.9 Creative Biolabs
    • 2.9.1 Creative Biolabs Details
    • 2.9.2 Creative Biolabs Major Business
    • 2.9.3 Creative Biolabs Biolayer Interferometry (BLI) Product and Services
    • 2.9.4 Creative Biolabs Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Creative Biolabs Recent Developments/Updates
  • 2.10 Biocult
    • 2.10.1 Biocult Details
    • 2.10.2 Biocult Major Business
    • 2.10.3 Biocult Biolayer Interferometry (BLI) Product and Services
    • 2.10.4 Biocult Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Biocult Recent Developments/Updates
  • 2.11 KMD Bioscience Co., Ltd
    • 2.11.1 KMD Bioscience Co., Ltd Details
    • 2.11.2 KMD Bioscience Co., Ltd Major Business
    • 2.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product and Services
    • 2.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 KMD Bioscience Co., Ltd Recent Developments/Updates

3 Competitive Environment: Biolayer Interferometry (BLI) by Manufacturer

  • 3.1 Global Biolayer Interferometry (BLI) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Biolayer Interferometry (BLI) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Biolayer Interferometry (BLI) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Biolayer Interferometry (BLI) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Biolayer Interferometry (BLI) Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Biolayer Interferometry (BLI) Manufacturer Market Share in 2023
  • 3.5 Biolayer Interferometry (BLI) Market: Overall Company Footprint Analysis
    • 3.5.1 Biolayer Interferometry (BLI) Market: Region Footprint
    • 3.5.2 Biolayer Interferometry (BLI) Market: Company Product Type Footprint
    • 3.5.3 Biolayer Interferometry (BLI) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biolayer Interferometry (BLI) Market Size by Region
    • 4.1.1 Global Biolayer Interferometry (BLI) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Biolayer Interferometry (BLI) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Biolayer Interferometry (BLI) Average Price by Region (2019-2030)
  • 4.2 North America Biolayer Interferometry (BLI) Consumption Value (2019-2030)
  • 4.3 Europe Biolayer Interferometry (BLI) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Biolayer Interferometry (BLI) Consumption Value (2019-2030)
  • 4.5 South America Biolayer Interferometry (BLI) Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Biolayer Interferometry (BLI) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 5.2 Global Biolayer Interferometry (BLI) Consumption Value by Type (2019-2030)
  • 5.3 Global Biolayer Interferometry (BLI) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 6.2 Global Biolayer Interferometry (BLI) Consumption Value by Application (2019-2030)
  • 6.3 Global Biolayer Interferometry (BLI) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 7.2 North America Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 7.3 North America Biolayer Interferometry (BLI) Market Size by Country
    • 7.3.1 North America Biolayer Interferometry (BLI) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Biolayer Interferometry (BLI) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 8.2 Europe Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Biolayer Interferometry (BLI) Market Size by Country
    • 8.3.1 Europe Biolayer Interferometry (BLI) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Biolayer Interferometry (BLI) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region
    • 9.3.1 Asia-Pacific Biolayer Interferometry (BLI) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Biolayer Interferometry (BLI) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 10.2 South America Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 10.3 South America Biolayer Interferometry (BLI) Market Size by Country
    • 10.3.1 South America Biolayer Interferometry (BLI) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Biolayer Interferometry (BLI) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biolayer Interferometry (BLI) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Biolayer Interferometry (BLI) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country
    • 11.3.1 Middle East & Africa Biolayer Interferometry (BLI) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Biolayer Interferometry (BLI) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Biolayer Interferometry (BLI) Market Drivers
  • 12.2 Biolayer Interferometry (BLI) Market Restraints
  • 12.3 Biolayer Interferometry (BLI) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biolayer Interferometry (BLI) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biolayer Interferometry (BLI)
  • 13.3 Biolayer Interferometry (BLI) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biolayer Interferometry (BLI) Typical Distributors
  • 14.3 Biolayer Interferometry (BLI) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
    According to our (Global Info Research) latest study, the global Biolayer Interferometry (BLI) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Biolayer Interferometry (BLI) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Biolayer Interferometry (BLI) market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Biolayer Interferometry (BLI) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Biolayer Interferometry (BLI) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Biolayer Interferometry (BLI) market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biolayer Interferometry (BLI)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biolayer Interferometry (BLI) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen, Creative Biolabs, Biocult, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Biolayer Interferometry (BLI) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Biolayer Interferometry (BLI) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Affinity and Kinetic Analysis
    Drug and Antibody Screening
    Drug and Antibody Discovery
    Protein Quantification
    Others
    Market segment by Application
    Pharmaceutical Industry
    Diagnostics
    Biotechnology
    Scientific Research
    Others
    Market segment by players, this report covers
    Ichor Life Sciences, Inc
    Creative BioMart
    GenScript
    ROCKLAND IMMUNOCHEMICALS, INC
    BPS Bioscience, Inc
    Creative Proteomics
    Creative Biostructure
    Profacgen
    Creative Biolabs
    Biocult
    KMD Bioscience Co., Ltd
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Biolayer Interferometry (BLI) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Biolayer Interferometry (BLI), with revenue, gross margin, and global market share of Biolayer Interferometry (BLI) from 2019 to 2024.
    Chapter 3, the Biolayer Interferometry (BLI) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biolayer Interferometry (BLI) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Biolayer Interferometry (BLI).
    Chapter 13, to describe Biolayer Interferometry (BLI) research findings and conclusion.

    Buy now